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Abstract
Problem
Chlamydia trachomatis infections are often associated with acute syndromes including cer-
vicitis, urethritis, and endometritis, which can lead to chronic sequelae such as pelvic inflam-
matory disease (PID), chronic pelvic pain, ectopic pregnancy, and tubal infertility. As
epithelial cells are the primary cell type productively infected during genital tract Chlamydia
infections, we investigated whether Chlamydia has any impact on the integrity of the host
epithelial barrier as a possible mechanism to facilitate the dissemination of infection, and
examined whether TLR3 function modulates its impact.
Method of study
We used wild-type and TLR3-deficient murine oviduct epithelial (OE) cells to ascertain
whether C. muridarum infection had any effect on the epithelial barrier integrity of these cells
as measured by transepithelial resistance (TER) and cell permeability assays. We next
assessed whether infection impacted the transcription and protein function of the cellular
tight-junction (TJ) genes for claudins1-4, ZO-1, JAM1 and occludin via quantitative real-time
PCR (qPCR) and western blot.
Results
qPCR, immunoblotting, transwell permeability assays, and TER studies show that Chla-
mydia compromises cellular TJ function throughout infection in murine OE cells and that
TLR3 deficiency significantly exacerbates this effect.
Conclusion
Our data show that TLR3 plays a role in modulating epithelial barrier function during Chla-
mydia infection of epithelial cells lining the genital tract. These findings propose a role for
TLR3 signaling in maintaining the integrity of epithelial barrier function during genital tract
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Chlamydia infection, a function that we hypothesize is important in helping limit the chlamyd-
ial spread and subsequent genital tract pathology.
Introduction
Chlamydia trachomatis is a gram-negative intracellular bacterium and the cause of the disease
chlamydia, which is the most common sexually transmitted infection in the United States,
with over 1.7 million cases reported in the US in 2017 alone [1]. Genital tract infections with
C. trachomatis are associated with many acute syndromes including cervicitis, urethritis, and
endometritis [2]. Complications from chronic infections include pelvic inflammatory disease
(PID) and its sequelae of chronic pelvic pain, ectopic pregnancy, and tubal infertility [3].
Although Chlamydia is treatable with antibiotics, infected individuals are often asymptomatic;
which facilitates the spread of the bacterium through further sexual contact. As a result, Chla-
mydia infections have continued to rise despite the implementation of screening and early
intervention strategies [4]. The ultimate goal in developing more effective therapeutic mea-
sures against Chlamydia infection is to identify aspects of host immunity that will augment
clearance of the pathogen while minimizing immune responses that lead to genital tract
pathology.
As an obligate intracellular pathogen, Chlamydiae are known to interact with host-cell pat-
tern recognition receptors (PRRs), including a variety of intracellular cytosolic receptors and
Toll-like receptors (TLRs) [5–10]. TLRs are PRRs that recognize conserved microbial mole-
cules or pathogen-associated molecular patterns (PAMPs) [11]. Stimulation of TLRs by chla-
mydial PAMPs triggers cytokine responses critical to the establishment of innate and adaptive
immune responses [5, 7, 12–15]. It is critically important to identify the TLRs that induce the
specific inflammatory mediators that cause scarring and fibrosis, and to define therapeutic
approaches to prevent this process.
TLR3 is a receptor for double-stranded RNA (dsRNA) and is known to activate transcrip-
tion of IFN-β via the adaptor protein Toll-IL-1 receptor (TIR) domain-containing adaptor
molecule-1 (TICAM-1) [also called TIR-domain-containing adapter-inducing IFN-β (TRIF)]
[16, 17]. TLR3 is expressed intracellularly and on the cell surface on human fibroblasts [17];
however, TLR3 has an exclusive intracellular expression in most other cell types [18–20].
TLR3 has been identified as the major MyD88-independent PRR stimulated in the type-1 IFN
responses to many different viral infections due to its intracellular localization [21–26]. Con-
versely, its role in bacterial infection is poorly understood, particularly since bacteria are not
known to possess a dsRNA moiety. We previously showed that C. muridarum infected murine
oviduct epithelial (OE) cells secrete IFN-β in a mostly TLR3 dependent manner and that they
demonstrate dramatic reductions in the syntheses of other inflammatory immune mediators
in addition to IFN-β [6, 8]. Results from our recent in vivo study show that TLR3-deficient
mice have significantly different levels of several key innate-immune factors secreted into their
genital tracts during C. muridarum infection, and demonstrate altered recruitment of CD4+ T-
cells to the reproductive tract when compared to wild-type control mice [27]. Because of this
altered immune response to C. muridarum infection, we routinely observe higher bacterial
burdens early and mid-infection, and more substantial reproductive tract pathology in the
TLR3-deficient mice. These findings have proved our hypothesis that a less than optimal
immune response in the TLR3-deficient mice increases the severity of Chlamydia infection,
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and provides an impetus to investigate putative mechanisms that are invoked to elicit the more
progressive disease in the TLR3-deficient mice.
In this study, we further delineate the role of TLR3 in genital tract pathology associated
with Chlamydia infection, by examining the impact that TLR3 signaling has on bolstering the
host’s protective epithelial barrier that is designed to limit the spread of infection. Here, we
show that Chlamydia has an impact on the stability and function of cellular TJs throughout
infection in murine OE cells, and that TLR3 function significantly modulates this effect.
Materials and methods
Ethics statement
C57BL/6J (control) and TLR3-deficient mice were purchased from The Jackson Laboratory
(Bar Harbor, ME) at 6–8 weeks of age. All mice were provided food and water ad libitum and
kept on a standard 12-hour light/dark cycle. All mice were given at least a 1-week period
where they were allowed to acclimate to their new environment. After acclimation, female
C57BL/6NJ and TLR3-deficient mice were injected with 2.5 mg Depo-Provera after being
briefly anesthetized with isoflurane before any experiment, and all mice were allowed to
recover for no less than 1-week after the Depo-Provera treatment. To alleviate any possible dis-
tress, the mice were also briefly anesthetized with isoflurane prior to either intravaginal infec-
tion with C. muridarum, the insertion of calcium alginate swabs, or the insertion of aseptic
vaginal sponges. All mice were monitored daily for lethargy, signs of vaginal bleeding, and
death. None of the mice exhibited morbidity during these studies. All mice were euthanized by
either exposure to isoflurane or inhalation of carbon dioxide, followed by exsanguination. The
Indiana University Institutional Animal Care and Use Committee (IACUC) approved all
experimental animal protocols. All care was used to ensure that steps were taken to ameliorate
animal suffering in all work involved in the removal of genital-tract tissue.
Cells and bacteria
The cloned oviduct epithelial cell lines OE-TLR3(-) and OE-129WT [6] were grown at 37˚C in
a 5% CO2 humidified incubator and maintained in epithelial-cell media: 1:1 Dulbecco’s modi-
fied Eagle medium:F12K (Sigma-Aldrich, St. Louis, MO), supplemented with 10% character-
ized fetal bovine serum (FBS) (HyClone), 2 mM L-alanyl-L-glutamine (Glutamax I; Gibco/
Invitrogen, Carlsbad, CA), 5μg of bovine insulin/ ml, and 12.5ηg/ ml of recombinant human
FGF-7 (keratinocyte growth factor; Sigma) as previously described [6, 28].
Mycoplasma-free C. muridarum Nigg, previously known as C. trachomatis strain (MoPn),
was grown and titrated in McCoy cells (ATCC) as described [28, 29]. Chlamydial elementary
bodies (EBs) were harvested from infected cells, resuspended in SPG buffer (250mM sucrose,
10mM sodium phosphate, and 5mM L-glutamic acid, pH 7.2), and quantified on McCoy cells
using the methodology described previously [8, 28, 30].
Mice and infections
Wild-type control mice C57BL/6NJ [Stock No 005304] and TLR3-deficient mice
B6N.129S1-Tlr3tm1Flv/J [Stock No 009675] were purchased from The Jackson Laboratory
(Bar Harbor, ME) at 6–8 weeks of age. All mice were housed in Indiana University Purdue
University-Indianapolis specific pathogen-free (SPF) facilities. Age-matched mice were used at
14–16 weeks for the experiments in this study. The Indiana University Institutional Animal
Care and Utilization Committee (IACUC) approved all experimental protocols.
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Infections of mice were done as described in [5] with some minor modifications. Groups of
6 mice (1 mock treated; 5 infected) were treated with 2.5mg of Depo-Provera (medroxyproges-
terone acetate; Pfizer; New York, NY) in 0.1 ml saline one week before vaginal infection with
105 IFU C. muridarum (approximately 100 times the ID50) in 10μl sucrose-phosphate-glu-
tamic acid (SPG) buffer (250mM sucrose, 10mM sodium phosphate, and 5mM L-glutamic
acid, pH 7.2). To procure genital tract tissue from the infected mice, we used the methodology
described in [31] with some modification. Briefly, the entire genital tract was sterilely har-
vested from each mouse on either day 3, day 5, or day 7 post-infection. The segment encom-
passing the oviduct and uterine horn was carefully excised from each side of the genital tract,
and both sides from the same mouse were combined to comprise the entire upper genital tract
(UGT) tissue sample from that particular mouse. Tissue samples were quickly frozen at -80˚C
until the time of use.
In vitro infection of the oviduct epithelial cell lines OE129WT and OE129TLR3(-/-) C19
were performed as described in [6, 32]. Briefly, the OE cells were plated in their respective cell-
culture plates and were infected when confluent. The cells were infected with an inoculum
containing anywhere from 1 to 10 inclusion-forming units (IFU) of C. muridarum/ cell
(depending upon the experiment), and the cell-culture plates were centrifuged 1000 x g for 1hr
at room temperature in a table-top centrifuge to synchronize infection prior to being returned
to the 37˚C CO2 incubator.
Measuring C. muridarum organism recovery from upper genital tract
tissue
We used a similar method to monitor the upper genital tract infection in mice as described
elsewhere [31]. To recover viable Chlamydia from the UGT of C. muridarum infected wild-
type and TLR3-deficient mice, each mouse’s UGT tissue sample was homogenized in 300μl of
SPG using a 2-ml Dounce tissue grinder (Sigma) and subsequently passaged through a
20-gauge syringe. After a brief sonication, the released chlamydial EBs were titrated on McCoy
cell monolayers as described previously in [8, 28, 30]. Briefly, chlamydial elementary bodies
harvested from infected tissue were serial diluted 1:10 in SPG and quantified as inclusion
forming units (IFUs) per milliliter on McCoy cell monolayers. The total number of IFUs per
ml was calculated based on the enumeration of fluorescent inclusion bodies in the cells
whereby antibody specific for chlamydial LPS was used to detect chlamydial inclusions in the
infected McCoy cells. Detection of the chlamydial LPS was done via Alexa Fluor 488 anti-
mouse IgG secondary antibody (Invitrogen/Life Technologies; Carlsbad, CA), and immuno-
staining results were scanned and recorded by EVOS imaging system (Thermo-Fisher, Pitts-
burgh, PA).
Electric Cell-Substrate Impedance Sensing (ECIS)
Trans-epithelial resistance (TER) of C. muridarum infected OE cell monolayers were mea-
sured with the ECIS system using the Zθ (Theta) model and using the 8W10E+ (8-well) arrays
(Applied Biophysics Inc; Troy, NY). Prior to seeding the cells, the array chambers were treated
with a 10mM solution of cysteine for 10 min at room temperature to stabilize the electrode.
After removing the stabilization solution, the wells were washed twice with sterile distilled
water and seeded with either the OE-129WT cells or the OE-TLR3(-) cells at a density of 105
cells/cm2 in 400ml total volume epithelial media to achieve rapid confluence. After brief cen-
trifugation for 10 min at 1000 x g to attach cells to the surface, the cells were incubated at 37˚C
in a CO2 incubator for 4hrs to become completely confluent, which was verified by microscopy
before proceeding to the next step. After 4hrs of incubation, IFN-β was added to specific wells
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containing OE-TLR3(-) cells to achieve a final concentration of 50U/ml and returned to the
CO2 incubator for an additional 1hr. After the 1hr incubation with IFN-β, all cells were
infected with a multiplicity of infection (MOI) of 1 IFU/cell using the method described
above. Resistance, capacitance, and impedance information were collected continuously for
48hrs post-infection. Each experiment had two replicate wells per array, and the experiment
was repeated at least six times.
Transwell cell permeability assays
OE-129WT and OE-TLR3(-) cells were seeded at a density of 105 cells/cm2 on the TC-coated
polyester membrane inserts from the Corning Transwell 24-well plate system (Costar; Bru-
math, France). Mock treatment, IFN-β pre-treatment, and infection with an MOI of 1 IFU/cell
C. muridarum were all performed as described above after cells had been growing in the CO2
incubator for 6hrs after seeding. FITC-dextran (molecular mass of 70kDa; Sigma) was used as
an index of macromolecular permeabilization: Briefly, FITC-dextran was added to epithelial
media to a final concentration of 1mg/mL and added to the upper chambers of the Transwell
system. The lower chamber contained 300μl epithelial media, and 150μL samples were taken
from the lower chamber at 6-hour intervals to measure the amount of FITC-dextran that tra-
versed the monolayer during that time interval. The same volume was immediately replen-
ished in the lower chamber with fresh epithelial medium to prevent fluid movement caused by
hydrostatic pressure. The fluorescence was measured with a BioTek FLx800 fluorimeter (Bio-
Tek; Winooski, VT) using 480nm and 520nm as the excitation and emission wavelengths,
respectively.
RNA purification and quantitative real-time polymerase chain reaction
(qPCR)
OE129-WT cells, OE-TLR3(-) cells, and OE-TLR3(-) cells that pre-treated with 50U/ml
recombinant IFN-β were grown to confluence before being either mock-infected or infected
with 10 IFU/ cell C. muridarum. The OE-TLR3(-) cells pre-treated with IFN-β had the 50U/
ml IFN-β added to the media 1hr before infection as described in [8]. Cell lysates were har-
vested at either 0, 8, 12, 20, or 36hr post-infection, and total cell RNA was isolated using the
RNeasy plus kit (Qiagen; Valencia, CA) according to manufacturer’s protocol. The DNA-free
RNA samples were quantified using the NanoDrop spectrophotometer (Thermo Scientific),
and cDNA was obtained with the Applied Biosystem’s high-capacity cDNA reverse transcrip-
tion kit (Thermo Fisher) using 500ng total cell RNA. Target gene cDNA was amplified using
Applied Biosystem’s TaqMan gene-expression master kit in reactions containing primers for
the various tight-junction (TJ) genes and/or the β-actin control primers (Table 1) according to
manufacturer’s protocol. Quantitative measurements were performed via ABI7500 real-time
PCR detection system (Thermo Fisher). Relative expression levels were measured as a fold
increase in mRNA expression versus mock controls and calculated using the formula 2−ΔΔCt as
described in [33].
SDS PAGE and Western blotting
OE-129WT cells, OE-TLR3(-) cells, and OE-TLR3(-) cells that pre-treated with 50U/ml
recombinant IFN-β were grown to confluence before being either mock-infected or infected
with 10 IFU/ cell C. muridarum. Cell lysates were harvested at either 0, 8, 12, 20, or 36hr post-
infection, and were analyzed for tight-junction protein expression by SDS-PAGE and subse-
quent Western blotting techniques as described previously [32]. In brief, equal protein
amounts were separated on 4–12% Tris-Glycine Gel (Novex, Invitrogen Carlsbad CA, USA)
TLR3 deficiency and loss of epithelial barrier integrity during Chlamydia infection
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and blotted onto PVDF membrane (Amersham Hybond, GE Healthcare Life Sciences; Chi-
cago, Illinois, USA). After blocking, PVDF membranes were immunoblotted with primary
antibodies: rabbit anti-mouse claudin-1 (1:200 dilution; catalog# 51–9000), rabbit anti-mouse
claudin-2 (1:100 dilution; catalog# 51–6100), rabbit anti-mouse claudin-3 (1:50 dilution; cata-
log# PA5-16867), mouse anti-mouse claudin-4 (1:50 dilution; catalog# 32–9400), rabbit anti-
mouse ZO-1(1:2000 dilution; catalog# 61–7300) and goat anti-mouse JAM1 (1:5000 dilution;
catalog# PA5-47059), all purchased from Invitrogen. Rabbit anti-mouse occludin (1:250 dilu-
tion; catalog# LS-B2187) was purchased from LsBio (LifeSpan BioSciences Inc., Seattle, WA)
and the monoclonal antibody specific for mouse β-actin (1:50000 dilution; catalog# A1978)
antibody was purchased from Sigma. The HRP conjugated goat anti-rabbit IgG (catalog#
32460), and goat anti-mouse IgG (catalog# 32430) were purchased from Thermo Scientific,
while the chicken anti-goat IgG (catalog# CkxGt-003-EHRPX) was purchased from Immu-
noReagent Inc. (Raleigh, NC). All HRP-conjugated antibodies were diluted to 1:7500 dilution
and served as secondary antibodies in this study. Detection of specific proteins was done using
the Super-Signal West-Dura extended duration substrate (Thermo Scientific) and was carried
out according to the manufacturer’s protocol. For quantification of western blots, western blot
images were analyzed with NIH’s ImageJ software according to the tutorial described on the
website: http://lukemiller.org/index.php/2010/11/analyzing-gels-and-western-blots-with-
image-j/. Statistical analysis on the obtained density values was carried out with Microsoft
Excel and the GraphPad Prism program. The relative band intensity of each tight-junction
protein was obtained by the normalization to the band intensity of the β-actin loading control.
Experiments were repeated at least three times.
Immunofluorescent staining of tight junction proteins
OE-129WT cells and OE-TLR3(-) cells were grown to confluence in 96-well Ibidi plates (Ibidi
USA; Fitchburg, Wisconsin) before being either mock-infected or infected with 1 IFU/ cell C.
muridarum at 37˚C for up to 36hrs. At the specified time-point, the cells were carefully rinsed
with PBS before being fixed 10 min at room temperature using 10% neutral-buffered formalin
(Sigma). The monolayers were washed at room temperature 3 times for 5 min using PBS.
After washing in PBS, the cells were blocked and permeabilized for 30 min using PBS contain-
ing 1% BSA and 0.1% saponin. After permeabilization, cells were washed in blocking buffer
(PBS + 1% BSA) at room temperature for 5 min, and the primary antibody (either Claudin-1;
1:50 dilution, ZO-1; 1:100 dilution, or JAM-1; 1:200 dilution) was added to the cells for 1hr at
room temperature. After washing at room temperature 3 times for 5 min using PBS, the cells
were then incubated in the dark at room temperature for 1hr using either goat anti-rabbit,
goat anti-mouse, or donkey anti-goat 2˚ antibody conjugated with Alexa Fluor-594 (1:1000
Table 1. Primers for qPCR.
Sense Primer Antisense Primer
CLDN1 5’-AGGAGCAGGAAAGTAGGACA-3’ 5’-GTCCCCCAACTTGAGATGTATG-3’
CLDN2 5’-AGCTGACTTCTTTCCTCCTTAC-3’ 5’-TCGCCTTTCTCTGGACCTA-3’
CLDN3 5’-GTCTGTCCTCTTCTAGCCTA-3’ 5’-CACTACCAGCAGTCGATGAAC-3’
CLDN4 5’-CACTCAGCACACCATGACTT-3’ 5’-CACTCAGCCTACACGTTACTC-3’
ZO-1 5’-GCCACTACAGTATGACCATCC-3’ 5’-AATGAATAATATCAGCACCATGCC-3’
OCLDN 5’-GTTGATCTGAAGTGATAGGTGGA-3’ 5’-CACTATGAAACAGACTACACGACA-3’
JAM-1 5’-ACGAGGTCTGTTTGAATTCCC-3’ 5’-GCCTATAGCCGTGGATACTTTG-3’
β-actin 5’-AGGTCTTTACGGATGTCAACG-3’ 5’-ATTGGCAACGAGCGGTT-3’
https://doi.org/10.1371/journal.pone.0207422.t001
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dilution, Molecular Probes). Finally, the cells were washed 3 times for 5 min using PBS and
counterstained with DAPI to identify the nuclear DNA. Duplicates processed without primary
antibodies served as negative controls. Fluorescence was imaged using a Leica DMI 6000B
inverted fluorescent microscope.
Statistical analysis
Numerical data are presented as mean ± (SD). All experiments were repeated at least three
times, and statistical significance was determined using Student’s two-tailed t-test unless stated
otherwise. 2-way ANOVA analyses in GraphPad Prism were used to analyze the differences in
IFUs recovered from mouse upper genital tract tissue homogenates. Statistically significant dif-
ferences are shown by asterisks (�), and with the minimum criteria being p<0.05.
Results
Chlamydia muridarum ascends more rapidly into the upper genital tract
tissues of TLR3-deficient mice
We previously showed that TLR3-deficient mice exhibited significantly higher levels of chla-
mydial shedding from the lower genital tract when compared to wild-type (WT) mice during
the first four weeks of infection [6, 27]. Additionally, our earlier in vitro studies showed that
Chlamydia replication in oviduct epithelial (OE) cells deficient in TLR3 was more robust than
in the wild-type OE cells [8]. The data from those previous experiments showed that TLR3 had
a biological impact on the innate immune response to Chlamydia infection in mice, and we
hypothesized that TLR3 deficiency might have a subsequent impact on Chlamydia’s ability to
spread and ascend the female genital tract. To ascertain whether TLR3’s function indeed has a
role in the chlamydial spread and ascension into the upper genital tract (UGT) tissue of female
mice, we infected WT and TLR3-deficient (TLR3-KO) mice with 105 IFU C. muridarum and
harvested the UGT tissue from mice at either day 3, 5, or 7 post-infection. As shown in Fig 1,
infectious chlamydial elementary bodies (EBs) were recovered from the UGT of the infected
mice, thus demonstrating that C. muridarum reaches the tissue encompassing the oviduct and
uterine horn as early as 3 days post-infection. We consistently recovered significantly more
infectious chlamydial progeny from TLR3-deficient mice at all time points tested in each
experiment. These findings are consistent with our previous reports of more robust Chlamydia
replication in the absence of TLR3 function [6, 8, 27]. The observation that there was signifi-
cantly more chlamydial progeny in the UGT tissues of mice early during infection supports
our hypothesis that TLR3 deficiency leads to a more progressive infection, increases chlamyd-
ial spread, and demonstrates a more rapid ascension of Chlamydia into the upper reproductive
tract tissues.
TLR3 deficiency augments the chlamydial degradation of OE cell TER
It has been demonstrated in other studies that Chlamydia infection can impact epithelial bar-
rier function by inducing the secretion of various inflammatory mediators that are hypothe-
sized to modulate the synthesis of host proteins that form cellular tight junctions (TJs) and
adherens junctions (AJs) [34–37]. To determine if TLR3 deficiency has any impact on Chlamy-
dia’s ability to affect host cell barrier integrity, we infected wild-type and TLR3-deficient OE
cells with 1 IFU/ cell C. muridarum and measured the trans-epithelial resistance (TER) of the
cell monolayers over a period of 48hrs in ECIS. As shown in Fig 2A, the TER in wild-type OE
cells is significantly increased in response to Chlamydia infection after 6hrs post-infection
when compared to infected TLR3-deficient OE cells and the mock controls. However, the TER
TLR3 deficiency and loss of epithelial barrier integrity during Chlamydia infection
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begins to precipitously decline after about 24hrs (40% reduction in TER in the wild-type OE
cells at the 48hr time point, p< 0.05). These data are in accordance with previous studies show-
ing a reduction in TER at a late time point during Chlamydia infection [34]. However, we did
not observe an initial increase in TER in the TLR3-deficient OE cells as we had seen in the
wild-type OE cells, which corroborates reports by others suggesting a critical role for TLR3 in
increasing epithelial barrier function early during the epithelial repair process [38, 39]. The
rate of degradation in TER was significantly higher in the TLR3-deficient OE cells, which
resulted in an almost 80% decline in TER by 36hrs post infection. We previously reported that
C. muridarum-induced synthesis of IFN-β in TLR3-deficient OE cells was significantly
reduced and that Chlamydia replication in the absence of TLR3-induced IFN-β was signifi-
cantly increased in those cells when compared to wild-type OE cells [6]. Pretreatment of
TLR3-deficient OE cells with 50U/ml exogenous IFN-β for 1hr before infection resulted in a
significant reduction chlamydial progeny; however, pre-treatment with exogenous IFN-β had
no significant impact on C. muridarum infection and replication in wild-type OE cells [8]. To
examine whether IFN-β has an impact on the more rapid decline of TER during TLR3 defi-
ciency, we pretreated TLR3-deficient OE cells with 50U/ml of exogenous IFN-β 1hr prior to
infection; however, the TLR3-deficient OE cells exhibited no significant change TER during
infection when compared to the untreated TLR3-deficient OE cells (Fig 2B). Also, we did not
see any significant difference in the TER of WT OE cell monolayers that were pre-treated with
50U/ml recombinant IFN-β for 1hr before infection (S1 Fig), indicating that IFN-β had no
impact on the TER during C. muridarum infection in either OE cell type. The ECIS data show
that TLR3 deficiency in oviduct epithelium led to a more rapid decline in TER during Chla-
mydia infection, and the rate of TER decline was not affected by the addition of exogenous
IFN-β which is known to restrict C. muridarum replication in these cells.
Fig 1. C. muridarum recovery from upper genital tract (UGT) tissue of wild-type and TLR3-KO mice. Genital tract
infections were performed, and UGT tissue was collected on days 3, 5, and 7 post-infection as described in Materials
and Methods. The live chlamydial organisms recovered from the UGT were titrated, and the results were expressed as
IFUs/ml recovered along the Y-axis. Data shown are pooled results of 3 individual experiments resulting in the total of
n = 15 mice for each strain on days 3, 5, and 7. IFU = inclusion forming units. The data are represented as mean (SD)
�� = p<0.005 and ��� = p<0.001 when comparing WT vs. TLR3-deficient mice on that given day.
https://doi.org/10.1371/journal.pone.0207422.g001
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Fig 2. TLR3 deficiency exacerbates the Chlamydia-induced attenuation of trans-epithelial resistance (TER) in
murine OE cell monolayers. TER was measured every three hours in mock and C. muridarum infected: A) WT vs.
TLR3-deficient OE cells, and B) TLR3-deficient OE cells vs. TLR3-deficient OE cells pre-treated with 50U/ml IFN-β
1hr prior to infection. TER at each time-point is relative to mock-infected controls of each respective cell line set at
100%. Data are representative of 6 independent experiments. WT = wild-type and TLR3(-) = TLR3-deficient OE cells.
The data are represented as mean (SD). Two-way ANOVA with Tukey’s multiple comparisons test applied. �P<0.05, ��
= p�0.0025, ��� = p 0.0003 thru 0.0001, ���� = p<0.0001 comparing WT and TLR3-deficient OE cells at the given time.
https://doi.org/10.1371/journal.pone.0207422.g002
TLR3 deficiency and loss of epithelial barrier integrity during Chlamydia infection
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TLR3 deficiency exacerbates the Chlamydia infection induced
macromolecular permeability in OE cell monolayers
We next performed transwell macromolecular permeability assays to probe the physiological
relevance of the pronounced decline of TER in TLR3-deficient OE cells during C. muridarum
infection. Wild-type and TLR3-deficient OE cells were either mock-infected or infected with 1
IFU/ cell C. muridarum to determine if the drop in TER coincided with increased permeability
of the OE cell monolayers to 70kDa FITC-dextran. As shown in Fig 3, C. muridarum infection
significantly increased the amount of 70kDa FITC-dextran allowed to pass through the OE cell
monolayers when compared to the mock-infected controls after about 18hrs post-infection in
both cell types. However, the amount of FITC-dextran that traversed the TLR3-deficient OE
cell monolayer was significantly higher than in wild-type cells after the 24hr time-point (P<
0.05; denoted by an asterisk). We did not see any significant difference in the macromolecular
permeability of either the WT or TLR3-deficient OE cell monolayer when the cells were pre-
treated with 50U/ml recombinant IFN-β for 1hr before infection (S2 Fig), indicating that IFN-
β had little impact on the macromolecular permeability of TLR3-deficient OE cells during C.
muridarum infection. The macromolecular permeability results corroborate the ECIS data
demonstrating that TLR3 deficiency leads to more dramatic reductions in TER in murine OE
cells. Collectively, the ECIS and transwell experiments indicate that TLR3-deficient OE cells
are more susceptible to Chlamydia infection-induced breakdown of the monolayer integrity,
and suggest that TLR3 signaling plays a substantial role in the maintenance of epithelial barrier
function in oviduct epithelium during Chlamydia infection.
The transcription of tight junction (TJ) genes are differentially regulated in
TLR3-deficient OE cells during Chlamydia infection
The more dramatic reduction in TER appears to coincide with increased macromolecular per-
meability in the TLR3-deficient OE cells late during C. muridarum infection. These results
imply that TLR3-deficiency leads to a more acute breakdown in the integrity cellular tight
junctions (TJs) and/or adherence junctions (AJs) that are known to be affected during cellular
invasion by specific viral and bacterial pathogens [34, 36, 37, 40–42]. To ascertain whether the
dissimilarity in macromolecular permeability and TER between the wild-type and TLR3-defi-
cient OE cells correlates with a differential regulation in TJ gene expression during Chlamydia
infection, we measured gene transcription levels of the candidate TJ proteins by quantitative
real-time-PCR (qPCR). OE129-WT, OE-TLR3(-), and OE-TLR3(-) cells pre-treated with IFN-
β were either mock-infected or infected with 10 IFU/ cell C. muridarum before being harvested
for total RNA isolation at 0, 8, 12, 20, and 36hrs post-infection. As shown in Fig 4, claudin-1
was significantly downregulated early (0-8h) and mid-infection (9-18h) in the OE129-WT
cells, but eventually recovered to the levels of the mock-infected controls by 20hrs post-infec-
tion. However, claudin-1 gene transcription levels were significantly higher in the OE129-WT
cells when compared to the mock-infected control cells by the 36hr time-point. In contrast,
claudin-1 transcription was not as affected early during infection in the OE-TLR3(-) cells, and
its expression levels were 3-fold lower than the OE129-WT cells at the 36hr time-point. Clau-
din-2 transcription was not very different between the two cell types, and its expression was
also slightly downregulated early and mid-infection in both OE cell types. Claudins 3 and 4
gene expression levels were upregulated in both cell types; however, their expression levels
were significantly reduced in the OE-TLR3(-) cells at most times past the 12hr time-point.
There was no significant impact on transcription of any of the claudin genes tested when IFN-
β was added to OE-TLR3(-) cells 1hr before infection, except for the 36hr timepoint when clau-
din-3 transcription was significantly higher in the IFN-β pre-treated TLR3-deficient OE cells.
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Fig 5 shows qPCR results of the Chlamydia-induced gene expression of ZO- 1, JAM-1, and
occludin in the OE129-WT, OE-TLR3(-), and IFN-β treated OE-TLR3(-) cells. As indicated,
ZO-1 transcription levels were evenly downregulated during C. muridarum infection in all cell
types, but gene expression levels began to rise in the OE129-WT cells starting at 20hrs post-
infection. By the 36hr time-point, ZO-1 gene expression levels were more than 2-fold higher in
the OE129-WT cells when compared to the OE-TLR3(-) cells. In contrast to ZO-1 results, we
saw an initial uneven downregulation in JAM-1 transcription, but it was the OE-TLR3(-) cells
that had a dramatic increase in JAM-1 gene expression starting at 20hrs post-infection. By the
36hr time-point, the JAM-1 gene expression was almost 8-fold higher in the OE-TLR3(-) cells
when compared to the OE-129WT cells.
Occludin transcription was significantly downregulated early during infection of the OE-
129WT cells but slowly increased to a little over a 2-fold difference in gene expression levels
versus the mock-infected cells at the 36hr time-point. In contrast, occludin transcription levels
remained relatively stable in the OE-TLR3(-) cells before increasing to almost 4-fold versus the
mock-infected controls at the 36hr time-point. Again, we saw no significant differences
between OE-TLR3(-) cells and IFN-β treated OE-TLR3(-) cells. However, we did notice that
the TJ gene expression levels trended towards the direction of their respective counterpart in
OE-129WT cells in all cases except for occludin, where it trended more towards the OE-TLR3
(-) cell results. Because OE-129WT cells secrete significantly higher amounts of C.
Fig 3. TLR3 deficiency leads increased rates of macromolecular permeability in OE cell monolayers during
Chlamydia infection. Macromolecular permeability assays were performed in WT and TLR3-deficient OE cell lines
that were either mock-infected or C. muridarum-infected at an MOI of 1 IFU/ cell. Relative permeability was measured
using a FITC-labeled dextran (70-kDa) probe. Samples were taken from the basolateral chamber of the transwell every
6hrs post-infection, and permeability was determined by increases in relative fluorescence compared to mock-infected
controls. Data are representative of three independent experiments. WT = wild-type and TLR3(-) = TLR3-deficient OE
cells. The data are represented as mean (SD). Two-way ANOVA with Tukey’s multiple comparisons test applied. ��� = p
0.0003 thru 0.0001, ���� = p<0.0001 comparing WT and TLR3-deficient OE cells at the given time.
https://doi.org/10.1371/journal.pone.0207422.g003
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muridarum-induced IFN-β starting as early as 2-3hr post-infection [43], we saw no significant
differences in the candidate TJ protein transcription levels when the OE-129WT cells were
pre-treated with 50U/ml of exogenous IFN-β (S3 and S4 Figs). Collectively, our data show that
TJ gene expression levels in OE cells are affected by Chlamydia infection, which supports the
findings of other investigators using different cell types [34, 35]. However, we show that the
Chlamydia’s impact on TJ gene expression in OE cells is differentially regulated during TLR3
deficiency.
TLR3 signaling has a differential impact on the synthesis, stability, and
cellular distribution of candidate TJ proteins during Chlamydia infection
of OE cells
We next sought to determine if the Chlamydia-induced changes in the mRNA expression lev-
els of candidate TJ genes translate into corresponding changes in their protein expression lev-
els and/or stability. As shown in Fig 6A, ZO-1 protein expression levels in OE-129WT cells
was rapidly diminished by 8hrs post-infection, was completely gone by 20hrs post-infection,
but that there was little evidence of protein degradation. In contrast, ZO-1 expression was also
expressed in the OE-TLR3(-) cells, but appeared to be a lot less stable and showing more signs
of protein degradation since there was no full-length ZO-1 protein at the 12hr time-point.
Occludin protein expression level and stability in OE-129WT cells remained steady through-
out infection. Occludin protein expression in the OE-TLR3(-) cells was significantly higher
immediately after infection (8hr time-point) when compared the OE-129WT cells but slightly
increased throughout the remainder of infection. The stability of the occludin protein in the
Fig 4. TLR3 deficiency dysregulates the Chlamydia-induced gene expression of the claudin integral membrane tight junction
(TJ) proteins. Gene expression levels of Claudins 1–4 were measured by qPCR at various times post-infection in C. muridarum
infected WT, TLR3-deficient, and TLR3-deficient OE cells that were pre-treated with 50U/ml recombinant IFN-β 1hr before
infection. Data are representative of three or more independent experiments. OE-129WT = wild-type and OE-TLR3(-) =
TLR3-deficient OE cells. The data are represented as mean (SD). � = p<0.05, �� = p<0.005, and ��� = p<0.001 when compared to
TLR3-deficient OE cells at the given time.
https://doi.org/10.1371/journal.pone.0207422.g004
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Fig 5. The Chlamydia-induced gene expression of the TJ proteins is impacted during TLR3 deficiency. Gene
expression levels of ZO-1, JAM-1, and occludin were measured by qPCR at various times post-infection in C.
muridarum infected WT, TLR3-deficient, and in TLR3-deficient OE cells that were pre-treated with 50U/ml
recombinant IFN-β 1hr before infection. Data are representative of three or more independent experiments. OE-
129WT = wild-type and OE-TLR3(-) = TLR3-deficient OE cells. The data are represented as mean (SD). � = p<0.05
and ��� = p<0.001 when comparing WT vs. TLR3-deficient OE cells at the given time.
https://doi.org/10.1371/journal.pone.0207422.g005
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Fig 6. TLR3 deficiency leads to altered TJ protein expression in OE cell monolayers during Chlamydia infection. WT,
TLR3-deficient, and IFN-β pre-treated TLR3-deficient OE cells were infected with 10 IFU/ cell C. muridarum for up to 36 hours
before cell lysates were harvested at the various time-points shown. Protein expression levels were measured by western blot analyses
for: (A) ZO-1, occludin, and claudin-1; (B) JAM1 and claudin-2; and (C) claudin-3. OE-129WT = wild-type and OE-TLR3(-) =
TLR3-deficient OE cells. Blots shown are representative data. Right-side plots show densitometry of tight-junction proteins
normalized to the β-actin control for the representative data. The relative band intensity is the ratio number of respective band
intensity for each TJ protein (minus background) at the indicated time-point, divided by the band intensity for β-actin (minus
background) at that specific time-point shown in the representative western blot data. Significance was determined by comparing the
ratio number of the representative data for WT and IFN-β pre-treated TLR3-deficient OE cells, to the ratio number of OE-TLR3(-)
cells divided by β-actin for three independent experiments. P-values were calculated using a two-tailed unpaired t-test, error bars
represent mean (SD) � = p<0.05 and �� = p<0.005 when compared to TLR3-deficient OE cells at the given time.
https://doi.org/10.1371/journal.pone.0207422.g006
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OE-TLR3(-) cells was mostly unaffected by the Chlamydia infection as it was in the OE-
129WT cells, and pre-treating the OE-TLR3(-) cells with IFN-β prior to infection had only a
minor impact on the stability and expression levels of both occludin and ZO-1.
The protein expression levels of claudins 1–3 were dramatically different between the OE-
129WT cells and the OE-TLR3(-) cells (Fig 6A–6C). As shown, claudin-2 and claudin-3 pro-
teins were expressed in the OE-129WT cells, and their expression levels either remained steady
or were increased late during infection, while claudin-1 protein expression appeared to be
diminished after the 20hr time-point. In contrast, the protein expression levels of claudins 1–3
were much lower in the OE-TLR3(-) cells; nonetheless, their expression levels were also mod-
erately impacted by the C. muridarum infection. Interestingly, pre-treatment of OE-TLR3(-)
cells with IFN-β prior to infection appeared to mildly but significantly increase the synthesis
and stability of claudin-3 at the 20hr time point, while substantially bolstering the synthesis
and stability of claudin-1 and claudin-2 throughout infection. These findings suggest that the
Chlamydia-induced IFN-β synthesized via TLR3-signalling pathways plays a role in regulating
the protein synthesis of these genes, while also simultaneously enhancing their protein stability
within the cell. In contrast to the claudin proteins, JAM-1 protein expression was substantially
higher in the OE-TLR3(-) cells when compared to the OE-129WT cells where it was barely
detectable on the immunoblot. Pretreating the OE-TLR3(-) cells with IFN-β before C. muri-
darum infection seemed to result in a differential synthesis of JAM-1 throughout Chlamydia
infection when compared to untreated OE-TLR3(-) cells, suggesting that the IFN-β synthe-
sized via TLR3-signalling pathways may play a role in regulating the protein expression levels
of JAM-1.
Fluorescent microscopy was also performed to assess protein expression levels and cellular
distribution of various TJ proteins in WT and TLR3-deficient OE cells over the course of Chla-
mydia infection. As shown in Fig 7, we observed a differential distribution of JAM-1, ZO-1,
and claudin-1 to the cellular TJs throughout Chlamydia infection that seemed to depend on
the functionality of TLR3. In corroboration with the western blot data, we saw substantially
higher cellular expression levels of JAM-1 during C. muridarum infection in the TLR3-defi-
cient OE cells, and its distribution along the outer membrane at cell-cell junctions increased at
late times post-infection. In contrast, JAM-1 protein expression levels were noticeably lower in
the OE-129WT cells and distribution at late times became increasingly cytoplasmic. ZO-1 pro-
tein expression levels along the outer membrane only slightly decreased by mid-infection in
the OE-129WT cells, but its distribution remained mostly stable at cell-cell barriers late in
infection even though its protein expression level had decreased. The expression and cellular
distribution of ZO-1 differed during TLR3-deficiency in that its protein expression levels dra-
matically decreased over the course of infection, and its distribution became increasingly cyto-
plasmic in the TLR3-deficient OE cells late during C. muridarum infection. Claudin-1 protein
expression levels remained mostly stable at mid-infection (12h) in the OE-129WT cells while
only slightly increasing very late during infection; however, its distribution remained mostly
stable at the cell-cell junctions throughout infection. Claudin-1 protein expression levels
seemed to slightly diminish at late times post-infection in the TLR3-deficient OE cells, and its
cellular distribution remained mostly cytoplasmic throughout infection. Results of the immu-
nofluorescence studies reveal that C. muridarum infection can impact the cellular distribution
of specific TJ proteins and likely the stability of cellular TJs of genital tract epithelium in vitro,
which a finding that supports the investigation of others [34, 35, 44]. Additionally, the immu-
nofluorescence data corroborate the western blot findings showing that TLR3 signaling plays a
role in mitigating Chlamydia’s impact on TJ protein expression and its stability. Collectively,
we demonstrate that TLR3 signaling plays a biological role in maintaining epithelial barrier
function, and our data implicate Chlamydia infection, TLR3, and the IFN-β synthesized
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through TLR3 signaling pathways in the assembly and stability of cellular tight junctions dur-
ing Chlamydia infection of OE cell monolayers.
Discussion
Our previous reports proposed a protective role for TLR3 signaling in the immune response to
Chlamydia infection in mice and suggested that TLR3 signaling triggers mechanisms that
Fig 7. TLR3 deficiency impacts the chlamydial-induced rearrangement of claudin-1, JAM-1, and ZO-1 in cellular tight
junctions. WT and TLR3-deficient OE cells were infected with a low MOI of 1 IFU/ cell C. muridarum for up to 36 hours before
cells were fixed at the listed time-point post infection and examined by immunofluorescence as described in Materials and
Methods. The intensity of the TJ fluorescence in the infected cells was differentially regulated throughout infection in the
TLR3-deficient OE cells when compared to WT OE cells. OE-WT = wild-type and OE-TLR3(-/-) = TLR3-deficient OE cells. All
images are 40x magnification and nuclei were counterstained with DAPI (blue).
https://doi.org/10.1371/journal.pone.0207422.g007
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bolster the host’s ability limit the spread of Chlamydia and attenuate genital tract pathogenesis
caused during infection. In this report, we investigated whether modulation of epithelial bar-
rier function within the genital tract would be an example of such a mechanism where TLR3
signaling can exert its role in limiting Chlamydia spread and subsequent reproductive tract
pathology. Our data showed that there were significantly higher amounts of C. muridarum in
the UGTs of TLR3-deficient mice within the first seven days of infection when compared to
wild-type controls. These findings corroborate our earlier reports showing that TLR3 defi-
ciency in mice leads to higher chlamydial loads in the LGT, but we now show that these mice
also suffer from a more rapid ascension of C. muridarum into the UGT.
The primary physical barrier in the female reproductive tract is the mucosal layer that lines
the vagina, uterus, and luminal surfaces of the oviduct. The mucosal layer of the reproductive
tract is an immunologically active layer that is comprised of an epithelial layer with tight cell-
to-cell contact, which overlaid by a viscous layer of mucus [45]. The impact of Chlamydia
infection on the mucosal barrier function has been previously investigated by others, and it
was shown that Chlamydia infection disrupts the expression of critical proteins that form the
cell-cell junctions (i.e., TJs and AJs) that play critical roles in forming intercellular adhesions
[34–36, 46, 47]. The disruption of these intercellular adhesions during infection by Chlamydia
is hypothesized to be an essential immune-evasion strategy that involves recognition of specific
chlamydial PAMPs, which then triggers signaling events that manipulate host-cell structure
and function to help facilitate its spread within the host [44, 46]. In addition to the chlamydial
downregulation in the secretion of specific immune regulators and anti-microbial peptides,
the chlamydial disruption of intercellular adhesions is also thought to play a significant role in
increasing host vulnerability to co-infection with other genital tract pathogens such as gonor-
rhea and HIV-1 [34].
The identification of specific cellular mechanisms that are involved in the disruption and
subsequent destabilization of epithelial barrier function during Chlamydia infection is a recent
area of study in the pathogenesis of genital tract Chlamydia infections. The chlamydial induc-
tion of TLR-dependent inflammatory mediators such as IFN-γ, TNFα, and IL-1β has been
shown to impact the gene expression level and the stability of TJ proteins and thereby inducing
significant changes in TER when compared to uninfected controls [35, 48–52]. Because IFN-γ,
TNFα, and IL-1β are all differentially expressed in the context of TLR3 deficiency in murine
OE cells and mice [8, 27], we hypothesized that TLR3 deficiency might have a significant
impact on the integrity of the epithelial barrier within the female reproductive tract during
Chlamydia infection, due to the altered expression of these and other key cytokines.
We showed that C. muridarum has a significant impact on the deterioration of TER in OE
cell monolayers during infection, and our findings support the investigations of others show-
ing that Chlamydia infection causes significant changes in TER in other cell types when com-
pared to uninfected controls [34, 35]. Also, we showed that there was a more rapid rate of
decline in TER in the TLR3-deficient OE cells, which corresponded with a significantly
increased rate in macromolecular permeability through the TLR3-deficient OE cell monolay-
ers after 24hrs post-infection (see Fig 3). Collectively, our data indicate that TLR3 deficiency
results in a more rapid breakdown in epithelial barrier function during Chlamydia infection,
and proposes the hypothesis that Chlamydia exploits this phenomenon during TLR3 defi-
ciency as a mechanism to accelerate its rate of ascent into the UGT of female mice early during
infection (Fig 1) and causing increased pathology relative to WT mice [27].
However, other possible mechanisms can contribute to increased chlamydial replication
and more rapid spread of C. muridarum into the UGTs of TLR3-deficient mice. For example,
it was shown that dysregulation in the syntheses of IFN-γ, IFN-β, and other inflammatory fac-
tors that formulate the immunological barrier of the female reproductive tract could lead to
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increased tissue pathology and have a direct impact on augmenting chlamydial replication and
enhancing its subsequent spread (reviewed in [53]); [8]). As a result, the increased chlamydial
load enhances the host’s exposure to chlamydial virulence factors such as the chlamydial prote-
ase-like activity factor (CPAF), which is proteolytic protein known to play a role in fostering
immune evasion by degrading transcription factors that are essential for regulating the expres-
sion of MHC molecules [54, 55]. CPAF is also known to directly enhance chlamydial viability
by preventing the release of noninfectious RBs from infected cells via degradation of pro-apo-
ptotic proteins, which inhibits cell death to facilitate completion of the chlamydial develop-
mental cycle [56]. CPAF also plays a role in enhancing chlamydial viability by stabilizing the
Chlamydia inclusion via Golgi-fragmentation as a mechanism to increase the transport of lip-
ids into the chlamydial inclusion membrane [57]. Taken together, the more rapid ascension of
Chlamydia into the UGTs of TLR3-deficient mice is likely the combined result of the dysregu-
lation in syntheses of multiple cytokines and chemokines that formulate the immunological
barrier in TLR3-deficient OE cells and mice [6, 8, 27], and a more rapid breakdown of the
physical epithelial barrier in TLR3-deficient OE cells that functions to prevent the spread and
transmission of sexually acquired infections [45, 58].
The exact link between TLR3 signaling and epithelial barrier function is unclear; however,
our data showed that TLR3 deficient cells were differentially regulated in the expression of
several candidate TJ genes in the C. muridarum-infected OE cells. Interestingly, our data
showed that some TJ genes were upregulated while some were downregulated in response to
Chlamydia infection and that some were also differentially regulated dependent upon the
functionality of TLR3. The precise relationship between a particular TJ protein synthesis
level and its specific impact on epithelial barrier function is unclear and requires further
study. Functionally, TJs are known to play a major role in controlling paracellular permeabil-
ity of the epithelial barrier, and the cellular pathways that modulate the individual TJ pro-
teins are regulated by various host and pathogenic organism factors including cytokines,
growth factors, virulence determinants from the invading pathogen, and hormones [59]. It is
likely that the variability in syntheses and secretion levels of numerous cytokines, chemo-
kines, and other innate-immune modulators during Chlamydia infection is the major con-
tributing factor to explain why we observed both up and downregulation of the individual TJ
genes.
The role of IFN-β in protecting the epithelial barrier was demonstrated in studies that
showed that IFN-β significantly attenuated the IFN-γ-induced decrease in occludin and VE-
cadherin expression in endothelial cells [60]. IFN-β has also been shown to be able to increase
the stability of candidate TJ proteins and prevent the macromolecular permeability in brain
endothelial cell monolayers that were removed from coculture with astrocytes or were treated
with histamine [61]. However, whereas we did not observe any significant impact on TER,
macromolecular permeability, or TJ transcription levels on a consistent basis when OE-TLR3
(-) cells were pre-treated with IFN-β prior to infection, we did notice some augmented protein
stability in claudin-1, claudin-2, and claudin-3 (to a lesser degree) in the IFN-β pre-treated
OE-TLR3(-) cells (Fig 6). These findings indicate that the chlamydial induction of TLR3-de-
pendent IFN-β during infection may play some role in the stabilization of the epithelial barrier,
and proposes a possible mechanism of action that IFN-β uses to help limit the replication
spread of C. muridarum as we have previously reported [8].
Finally, our data propose a role for TLR3 signaling in maintaining the integrity of epithe-
lial barrier function during genital tract Chlamydia infection; albeit a function that we
hypothesize is important in helping contain the bacterial spread, but one that eventually
becomes overwhelmed during productive infections as the pathogen ascends into the UGT.
We show that TLR3 deficiency leads to more rapid ascension into the UGT of infected mice,
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and we attribute the more rapid ascension to dysregulation in the C. muridarum-induced
syntheses of critical immune modulators and the increased infection-induced disruption of
cell-cell junctions. We are the first to report a role for TLR3 in the maintenance of barrier
integrity in oviduct epithelium during genital tract chlamydial infections; however, our work
here corroborates a prior study in which the investigators reported a role for TLR3 in normal
skin barrier repair following UVB damage [38]. In that study, the authors report changes to
TER, paracellular transport of fluorescein-labeled sodium, and TJ protein expression when
human keratinocytes were exposed to the TLR3 agonist poly-IC. The poly-IC was used to
simulate the induction of snRNAs that are hypothesized to trigger TLR3 responses during
UVB damage [39]. Our studies also parallel in that the prevailing hypothesis in both of our
investigations involve a putative mechanism whereby TLR3 elicits this barrier maintenance
function via cytokines and chemokines that are triggered upon stimulation by its appropriate
PAMP. The identification of the specific immune factor that affects each specific aspect of
the epithelial barrier function are subjects of our future investigations into this
phenomenon.
Supporting information
S1 Fig. Trans-epithelial resistance (TER) in murine wild-type OE cell monolayers. TER was
measured every three hours in mock and C. muridarum infected: WT OE cells and WT OE
cells pre-treated with 50U/ml IFN-β 1hr prior to infection. TER at each time-point is relative
to Mock-infected controls of each respective OE cell condition set at 100%. Data are represen-
tative of 6 independent experiments. WT = wild-type OE cells.
(TIF)
S2 Fig. Macromolecular permeability in WT and TLR3-deficient OE cell monolayers that
were pre-treated with IFN-β prior to Chlamydia infection. Macromolecular permeability
assays were performed in (A) TLR3-deficient and (B) WT OE cell lines that were either
untreated or pre-treated with 50U/ml recombinant IFN-β 1hr before being either mock-
infected or C. muridarum-infected at an MOI of 1 IFU/ cell. Relative permeability was mea-
sured using a FITC-labeled dextran (70-kDa) probe. Samples were taken from the basolateral
chamber of the transwell every 6hrs post-infection, and permeability was determined by
increases in relative fluorescence compared to mock-infected controls. Data are representa-
tive of three independent experiments. WT = wild-type and TLR3(-) = TLR3-deficient OE
cells.
(TIF)
S3 Fig. Chlamydia-induced gene expression of the claudin integral membrane tight junc-
tion (TJ) proteins. Gene expression levels of Claudins 1–4 were measured by qPCR at various
times post-infection in C. muridarum infected WT OE cells that were either mock-treated or
pre-treated with 50U/ml recombinant IFN-β 1hr before infection. Data are representative of
three or more independent experiments. OE-129WT = wild-type OE cells.
(TIF)
S4 Fig. Chlamydia-induced gene expression of tight junction (TJ) proteins. Gene expres-
sion levels of ZO-1, JAM-1, and occludin were measured by qPCR at various times post-infec-
tion in C. muridarum infected WT OE cells that were either mock-treated or pre-treated with
50U/ml recombinant IFN-β 1hr before infection. Data are representative of three or more
independent experiments. OE-129WT = wild-type OE cells.
(TIF)
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